FDA product approval
not approved. FDA identifies this investigational substance as unapproved.
GLP-1 and incretin · compound · checked 2026-10-09
Cagrilintide math uses the listed vial sizes on this card and the liquid you type. Concentration in mcg per mL is vial milligrams times 1000, divided by milliliters. A U-100 syringe has 100 marks per milliliter, so each unit is that concentration divided by 100. Example numbers so you can see the math: a 5 mg listing plus 2 mL of liquid. Change any number and the units change. Try the numbers. A research-market vial is not the same material used in a trial.
Last checked Oct 9, 2026 by PepBear. Not medical advice.
U-100 math for listed Cagrilintide sizes. Each cell is micrograms per syringe mark if you add that much liquid. The table does the same math as the calculator. It does not pick an amount for you.
| Listed vial | 1 mL liquid | 2 mL liquid | 3 mL liquid |
|---|---|---|---|
| 5 mg | 50 | 25 | 16.7 |
| 10 mg | 100 | 50 | 33.3 |
The amylin path is different from GLP-1, though combination trials with semaglutide exist. A research C-10 vial is not trial material. The mechanism language is receptor science. It is not a wellness claim.
Investigational long-acting amylin analogue.
FDA product approval
not approved. FDA identifies this investigational substance as unapproved.
Compounding
restricted. FDA states this substance cannot be used in compounding under federal law.
Research
investigational. Human obesity trials; investigational evidence is not product approval.
Sport
unknown. Not individually verified; consult the current sport rules. Absence of a listing is not permission.
Phase 2 work (PMID 34798060) reported weight results in studied adults. Later combination programs (CagriSema / REDEFINE family) are separate plans with their own citations when added. Stomach side effects appear in the incretin-plus-amylin papers. Trial findings stay inside their group, length, and product. A C-10 research listing does not inherit a combination-trial schedule just because both names mention amylin.
We mark the cited papers as B. That is our label for how strong those papers are. It does not say the compound works.
The catalog does not record a single hour value. No verified formulation-specific human estimate in this source set; no guessed value is supplied.
Listed sizes are 5 mg and 10 mg. Do not copy a combination-trial schedule onto a single research vial. Hold the carton.
People using PepBear often log: Existing clinician-directed records, symptoms and dated health measurements. Record missing data; trends do not demonstrate causation.
Study evidence is not product approval. FDA records this substance as unapproved and restricted for compounding as of the catalog check date.
This page does not treat CagriSema as a stack product. Combination trial names belong in a later compare or research card with their own citations.
Units = (amount in mcg ÷ (vial mg × 1000 ÷ water mL)) × 100 on a U-100 syringe. Enter the three numbers. The chart shows the same math for each listed vial size and 1, 2 or 3 mL of liquid.
A U-100 barrel is easy to misread below about 5 marks. That is a measuring warning. The page does not tell you to take more.
A licensed clinician must interpret the evidence for your situation. This entry provides education, not treatment instructions. Not medical advice. PepBear does not pick a dose, a cycle, or a seller.